¼¼°èÀÇ »ý¹° ½Ã·á äÃë ŰƮ ½ÃÀå
Biological Sample Collection Kits
»óǰÄÚµå : 1777857
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 383 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,180,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,541,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ »ý¹° ½Ã·á äÃë ŰƮ ½ÃÀåÀº 2030³â±îÁö 132¾ï ´Þ·¯¿¡ À̸¦ Àü¸Á

2024³â¿¡ 88¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â »ý¹° ½Ã·á äÃë ŰƮ ¼¼°è ½ÃÀåÀº 2024-2030³â°£ CAGR 7.0%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 132¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ½º¿ÒÀº CAGR 7.2%¸¦ ³ªÅ¸³»°í, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 39¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¹ÙÀÌ·¯½º ¿î¼Û ¸Åü ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£Áß CAGR 6.7%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 24¾ï ´Þ·¯, Áß±¹Àº CAGR 11.0%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹Ãø

¹Ì±¹ÀÇ »ý¹° ½Ã·á äÃë ŰƮ ½ÃÀåÀº 2024³â¿¡ 24¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 28¾ï ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 11.0%·Î ÃßÁ¤µË´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î¼­´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£Áß CAGRÀº °¢°¢ 3.5%¿Í 6.8%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 4.6%¸¦ ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù.

¼¼°èÀÇ »ý¹° ½Ã·á äÃë ŰƮ ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

»ý¹° ½Ã·á äÃë ŰƮ°¡ ³Î¸® »ç¿ëµÇ´Â ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

»ý¹° ½Ã·á äÃë ŰƮ´Â Ç÷¾×, Ÿ¾×, ¼Òº¯, Á¶Á÷ µîÀÇ »ý¹°ÇÐÀû ½Ã·á¸¦ Á¤È®Çϰí È¿À²ÀûÀ¸·Î äÃëÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÖ¸ç, Çö´ëÀÇ ÀÇ·á, Áø´Ü, ¿¬±¸¿¡ ÇʼöÀûÀÎ ¿ä¼Ò·Î ÀÚ¸® Àâ¾Ò½À´Ï´Ù. À̵é ŰƮ´Â Áúº´ Áø´Ü, ¹ýÀÇÇÐ ºÐ¼®, À¯ÀüÀÚ °Ë»ç, ½Å¾à °³¹ß µî ´Ù¾çÇÑ ÀÇ·á ºÐ¾ß¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¾Ï, ´ç´¢º´, È£Èí±â Áúȯ µî ¸¸¼ºÁúȯ ¹× °¨¿°¼º Áúȯ Áõ°¡·Î ÀÎÇØ »ý¹°ÇÐÀû °ËüÀÇ ¹«°á¼º°ú ¾ÈÁ¤¼ºÀ» º¸ÀåÇÏ´Â °íǰÁú ½Ã·áäÃë ŰƮ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀçÅà Áø´Ü °Ë»çÀÇ È®´ë·Î »ý¹°ÇÐÀû °Ëü äÃë ŰƮ ½ÃÀåÀÌ ´õ¿í Ȱ¼ºÈ­µÇ°í ÀÖÀ¸¸ç, °³ÀÎÀÌ ÀÇ·á±â°üÀ» ¹æ¹®ÇÏÁö ¾Ê°íµµ °£ÆíÇÏ°Ô °Ëü¸¦ äÃëÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ º¯È­´Â ƯÈ÷ Äڷγª19 ÆÒµ¥¹Í ÀÌÈÄ µÎµå·¯Áö°Ô ³ªÅ¸³µÀ¸¸ç, ºÐ»êÇü °Ë»ç¿Í ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µÀÇ Á߿伺ÀÌ ºÎ°¢µÇ¾ú½À´Ï´Ù. ¶ÇÇÑ, °³ÀÎ ¸ÂÃãÇü ÀÇ·á¿Í Á¤¹Ð Áø´ÜÀÌ È®»êµÊ¿¡ µû¶ó Á¾ÇÕÀûÀÎ À¯Àüü ¹× ÇÁ·ÎÅ×¿È ºÐ¼®À» °¡´ÉÇÏ°Ô Çϰí ȯÀÚ °á°ú¿Í Áúº´ ¿¹¹æ Àü·«À» °³¼±ÇÒ ¼ö ÀÖ´Â °í±Þ ½Ã·á ¼öÁý ¼Ö·ç¼Ç¿¡ ´ëÇÑ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

±â¼ú ¹ßÀüÀº ¾î¶»°Ô »ùÇà ¼öÁý ŰƮ¸¦ °³¼±Çϰí Àִ°¡?

½Ã·á äÃë ±â¼úÀÇ Çõ½ÅÀ¸·Î »ý¹° ½Ã·á äÃë ŰƮÀÇ È¿À²¼º, Á¤È®¼º, »ç¿ë ÆíÀǼºÀÌ Å©°Ô Çâ»óµÇ¾ú½À´Ï´Ù. °¢ Á¦Á¶¾÷üµéÀº DNA, RNA, ´Ü¹éÁúÀÇ ¹«°á¼ºÀ» Àå±â°£ À¯ÁöÇÏ´Â ¾ÈÁ¤È­Á¦¸¦ °³¼±ÇÑ Å°Æ®¸¦ °³¹ßÇÏ¿© ´Ù¿î½ºÆ®¸² ºÐ¼®¿¡¼­ º¸´Ù ½Å·ÚÇÒ ¼ö ÀÖ´Â °á°ú¸¦ º¸ÀåÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¸¶ÀÌÅ©·ÎÇ÷çÀ̵ñ½º ±â¼ú°ú ·¦¿ÂĨ µð¹ÙÀ̽ºÀÇ ¹ßÀüÀ¸·Î ÀÎÇØ ½Ã·á äÃë ½Ã½ºÅÛÀÇ ¼ÒÇüÈ­°¡ °¡´ÉÇØÁ® ½Ã·á ¿À¿°ÀÇ À§ÇèÀÌ °¨¼ÒÇÏ°í ¿î¼Û È¿À²ÀÌ Çâ»óµÇ¾ú½À´Ï´Ù. ¶Ç ´Ù¸¥ Å« ±â¼úÀû µµ¾àÀº ½º¸¶Æ® °Ëü äÃë ŰƮ¿Í µðÁöÅÐ Çコ Ç÷§Æû°úÀÇ ÅëÇÕÀÔ´Ï´Ù. ÀÌ·¯ÇÑ Ä¿³ØÆ¼µå ¼Ö·ç¼ÇÀº ½Ã·áÀÇ ¹«°á¼º, º¸°ü Á¶°Ç, ¿î¼Û ¹°·ù¸¦ ½Ç½Ã°£À¸·Î ÃßÀûÇÒ ¼ö ÀÖ¾î ¿À·ù ¹× ½Ã·á º¯Áú °¡´É¼ºÀ» ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù. AI ±â¹Ý Áø´Ü ¹× ÀÚµ¿È­µµ ½Ã·á äÃë ÃÖÀûÈ­¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖÀ¸¸ç, »ý¹°ÇÐÀû ½Ã·á¸¦ º¸´Ù ºü¸£°í Á¤È®ÇÏ°Ô ºÐ¼®ÇÒ ¼ö ÀÖµµ·Ï µ½°í ÀÖ½À´Ï´Ù. ½ÇÇè½Ç°ú ¿¬±¸¼Ò°¡ µðÁöÅÐ ¿öÅ©Ç÷ο츦 °è¼Ó äÅÃÇÔ¿¡ µû¶ó ±â¼úÀûÀ¸·Î °­È­µÈ ½Ã·á äÃë ŰƮ¿¡ ´ëÇÑ ¼ö¿ä°¡ Å©°Ô Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

»ý¹° ½Ã·áäÃë ŰƮÀÇ ¼ºÀåÀ» °ßÀÎÇÏ´Â ½ÃÀå µ¿ÇâÀº?

ºñħ½ÀÀû, Àúħ½ÀÀû ½Ã·á äÃë·ÎÀÇ ÀüȯÀº ½ÃÀå ¼ºÀåÀ» ÁÖµµÇÏ´Â °¡Àå Áß¿äÇÑ Æ®·»µå Áß ÇϳªÀÔ´Ï´Ù. Ÿ¾× ±â¹Ý ¹× °ÇÁ¶ Ç÷¾× ¹ÝÁ¡ äÃë ŰƮ´Â »ç¿ë ÆíÀǼº, ȯÀÚÀÇ ºÒÆíÇÔ °¨¼Ò, ÀçÅà °Ë»ç ¼Ö·ç¼Ç°úÀÇ È£È¯¼ºÀ¸·Î ÀÎÇØ ¸¹Àº »ç¶ûÀ» ¹Þ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºñħ½ÀÀû ¹æ¹ýÀº ±âÁ¸ äÇ÷ÀÌ ¾î·Æ°í ħ½ÀÀûÀÏ ¼ö ÀÖ´Â ¼Ò¾Æ ¹× ³ë³âÃþ¿¡¼­ ƯÈ÷ À¯¿ëÇÕ´Ï´Ù. ½ÃÀåÀ» Çü¼ºÇÏ´Â ¶Ç ´Ù¸¥ Áß¿äÇÑ Æ®·»µå´Â ¹ÙÀÌ¿À¹ðÅ©¿Í Àӻ󿬱¸ÀÇ Á߿伺ÀÌ °­Á¶µÇ°í ÀÖ´Ù´Â Á¡ÀÔ´Ï´Ù. Á¾´Ü ¿¬±¸, ¿ªÇÐ ¿¬±¸, ¹ÙÀÌ¿À¸¶Ä¿ Ž»öÀ» À§ÇÑ °íǰÁú »ý¹°ÇÐÀû »ùÇÿ¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó Ç¥ÁØÈ­µÈ °íÃæ½Çµµ »ùÇà äÃë ŰƮ¿¡ ´ëÇÑ ÅõÀÚ°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Á¦¾à»ç, Çмú±â°ü, CRO(ÀǾàǰ °³¹ß ¼öʱâ°ü)´Â ¿¬±¸ÀÇ ÀçÇö¼º°ú È®À强À» ³ôÀ̱â À§ÇØ Ã·´Ü ½Ã·áäÃë ±â¼ú¿¡ ´ëÇÑ ÀÇÁ¸µµ¸¦ ³ôÀ̰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ±ÔÁ¦ ±â°üÀº ½Ã·á ¼öÁý ¹× ¿î¼Û¿¡ ´ëÇÑ ¾ö°ÝÇÑ °¡À̵å¶óÀÎÀ» Á¦½ÃÇϰí Àֱ⠶§¹®¿¡ Á¦Á¶¾÷ü´Â ¼¼°è ǰÁú ±âÁذú »ý¹°ÇÐÀû ¾ÈÀü¼º ÇÁ·ÎÅäÄÝÀ» ÁؼöÇϴ ŰƮ¸¦ °³¹ßÇØ¾ß ÇÕ´Ï´Ù.

»ý¹° ½Ã·á äÃë ŰƮ ½ÃÀåÀÇ ÁÖ¿ä ¼ºÀå ÃËÁø¿äÀÎÀº ¹«¾ùÀΰ¡?

»ý¹°°Ëü äÃë ŰƮ ½ÃÀåÀÇ ¼ºÀåÀº °¨¿°¼º Áúȯ ¹× ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡, ÀçÅà Áø´Ü °Ë»çÀÇ È®´ë, Á¤¹ÐÀÇ·áÀÇ ¹ßÀü µî ¿©·¯ ¿äÀο¡ ÀÇÇØ ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù. À¯ÀüüÇÐ, ´Ü¹éÁúüÇÐ, ¾×ü»ý°Ë ºÐ¾ß¿¡¼­ °íǰÁú »ý¹°ÇÐÀû »ùÇÿ¡ ´ëÇÑ ¼ö¿ä´Â ¿¬±¸ÀÚ ¹× ÀÓ»óÀǵéÀÌ ½Å·ÚÇÒ ¼ö ÀÖ°í È¿À²ÀûÀÎ ¼öÁý ¹æ¹ýÀ» ã°í ÀÖ¾î ½ÃÀå È®´ë¿¡ ´õ¿í ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. ¿ø°ÝÀÇ·á¿Í ºÐ»êÇü ÀÓ»ó½ÃÇèÀÇ ºÎ»óµµ »ýü ½Ã·áäÃë ŰƮÀÇ Ã¤Åà Ȯ´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. Á¡Á¡ ´õ ¸¹Àº ȯÀÚ¿Í ¿¬±¸ÀÚµéÀÌ ¿ø°ÝÁö¿¡¼­ ½Ã·á äÃë¿¡ ÀÇÁ¸ÇÏ´Â °¡¿îµ¥, ½Ã·áÀÇ ¾ÈÁ¤¼º, Á¤È®ÇÑ ¶óº§¸µ, ÇÕ¸®ÀûÀÎ ¿î¼ÛÀ» º¸ÀåÇϴ ŰƮÀÇ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Áø´Ü °Ë»ç¿¡¼­ AI¿Í ÀÚµ¿È­ÀÇ ¿ªÇÒÀÌ Áõ°¡ÇÔ¿¡ µû¶ó µðÁöÅÐ Çコ »ýŰè¿Í ¿øÈ°ÇÏ°Ô ÅëÇյǴ ½º¸¶Æ® °Ëü ¼öÁý ¼Ö·ç¼ÇÀÇ °³¹ßÀÌ °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù. ÀÇ·á ¹× ¿¬±¸ ±â°üÀÌ È¿À²¼º°ú Á¤È®¼ºÀ» ÃÖ¿ì¼± °úÁ¦·Î »ï°í ÀÖ´Â °¡¿îµ¥, Á¤È² Á¶»ç ½ÃÀåÀº Áö¼ÓÀûÀ¸·Î ¼ºÀåÇÏ¿© Áø´Ü ¹× »ý¹° ÀÇÇÐ ¿¬±¸ÀÇ Àü¸ÁÀ» ¹Ù²Ü °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ºÎ¹®

Á¦Ç° À¯Çü(¸éºÀ, ¹ÙÀÌ·¯½º ¿î¼Û ¹èÁö, äÇ÷ ŰƮ, ä´¢ ŰƮ, ±âŸ Á¦Ç° À¯Çü), ¿ëµµ(Áø´Ü ¿ëµµ, ¿¬±¸ ¿ëµµ), ÃÖÁ¾ ¿ëµµ(º´¿ø ¹× Áø·á¼Ò, Áø´Ü¼¾ÅÍ, ȨÄɾî, ±âŸ ÃÖÁ¾ ¿ëµµ)

Á¶»ç ´ë»ó ±â¾÷ ¿¹

AI ÅëÇÕ

Global Industry Analysts´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AIÅø¿¡ ÀÇÇØ¼­, ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM³ª ¾÷°èº° SLM Äõ¸®¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ´ë·® ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÍ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Biological Sample Collection Kits Market to Reach US$13.2 Billion by 2030

The global market for Biological Sample Collection Kits estimated at US$8.8 Billion in the year 2024, is expected to reach US$13.2 Billion by 2030, growing at a CAGR of 7.0% over the analysis period 2024-2030. Swabs, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$3.9 Billion by the end of the analysis period. Growth in the Viral Transport Media segment is estimated at 6.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.4 Billion While China is Forecast to Grow at 11.0% CAGR

The Biological Sample Collection Kits market in the U.S. is estimated at US$2.4 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.8 Billion by the year 2030 trailing a CAGR of 11.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.5% and 6.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.6% CAGR.

Global Biological Sample Collection Kits Market - Key Trends & Drivers Summarized

Why Are Biological Sample Collection Kits Gaining Widespread Adoption?

Biological sample collection kits have become an essential component of modern healthcare, diagnostics, and research, facilitating the accurate and efficient collection of biological specimens such as blood, saliva, urine, and tissue. These kits play a critical role in various medical applications, including disease diagnosis, forensic analysis, genetic testing, and drug discovery. The rise in chronic and infectious diseases, including cancer, diabetes, and respiratory conditions, has driven an increased demand for high-quality sample collection kits that ensure the integrity and stability of biological specimens. The expansion of at-home diagnostic testing has further propelled the market for biological sample collection kits, allowing individuals to collect samples conveniently without visiting healthcare facilities. This shift is particularly evident in the wake of the COVID-19 pandemic, which highlighted the importance of decentralized testing and remote patient monitoring. Additionally, the growing prevalence of personalized medicine and precision diagnostics has increased the need for advanced sample collection solutions that enable comprehensive genomic and proteomic analysis, improving patient outcomes and disease prevention strategies.

How Are Technological Advancements Improving Sample Collection Kits?

Innovations in sample collection technology are significantly enhancing the efficiency, accuracy, and user-friendliness of biological sample collection kits. Manufacturers are developing kits with improved stabilization agents that preserve DNA, RNA, and protein integrity for extended periods, ensuring more reliable results for downstream analysis. Additionally, advancements in microfluidic technology and lab-on-a-chip devices are enabling the miniaturization of collection systems, reducing sample contamination risks and improving transport efficiency. Another major technological leap is the integration of smart sample collection kits with digital health platforms. These connected solutions allow real-time tracking of sample integrity, storage conditions, and transportation logistics, reducing the likelihood of errors and sample degradation. AI-driven diagnostics and automation are also playing a crucial role in optimizing sample collection, allowing for faster and more precise analysis of biological specimens. As laboratories and research facilities continue to adopt digital workflows, the demand for technologically enhanced sample collection kits is expected to rise substantially.

What Market Trends Are Driving the Growth of Biological Sample Collection Kits?

The shift toward non-invasive and minimally invasive sample collection methods is one of the most significant trends driving market growth. Saliva-based and dried blood spot collection kits are gaining traction due to their ease of use, reduced discomfort for patients, and compatibility with home-based testing solutions. These non-invasive techniques are particularly valuable in pediatric and geriatric populations, where traditional blood draws can be challenging and invasive. Another key trend shaping the market is the rising emphasis on biobanking and clinical research. The growing demand for high-quality biological samples in longitudinal studies, epidemiological research, and biomarker discovery is fostering investment in standardized and high-fidelity sample collection kits. Pharmaceutical companies, academic institutions, and contract research organizations (CROs) are increasingly relying on advanced sample collection technologies to enhance the reproducibility and scalability of their studies. Additionally, regulatory agencies are imposing stringent guidelines on sample collection and transport, prompting manufacturers to develop kits that comply with global quality standards and biosafety protocols.

What Are the Key Growth Drivers for the Biological Sample Collection Kits Market?

The growth in the Biological Sample Collection Kits market is driven by several factors, including the increasing prevalence of infectious and chronic diseases, the expansion of home-based diagnostic testing, and advancements in precision medicine. The demand for high-quality biological samples in genomics, proteomics, and liquid biopsy applications is further fueling market expansion, as researchers and clinicians seek reliable and efficient collection methods. The rise of telemedicine and decentralized clinical trials is also contributing to the increased adoption of biological sample collection kits. With more patients and researchers relying on remote sample collection, the need for kits that ensure sample stability, accurate labeling, and streamlined transportation has intensified. Additionally, the growing role of AI and automation in diagnostic testing is accelerating the development of smart sample collection solutions that integrate seamlessly with digital health ecosystems. As healthcare and research institutions continue to prioritize efficiency and accuracy, the market for biological sample collection kits is expected to experience sustained growth, transforming the landscape of diagnostics and biomedical research.

SCOPE OF STUDY:

The report analyzes the Biological Sample Collection Kits market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Swabs, Viral Transport Media, Blood Collection Kits, Urine Collection Kits, Other Product Types); Application (Diagnostics Application, Research Application); End-Use (Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â